Thursday, March 30th, 2023 14:37:26

Efficacy analysis demonstrates COVAXIN to be 77.8% effective against symptomatic COVID-19; 93.4% effective against severe symptomatic COVID-19: Lancet Study

Updated: November 12, 2021 10:07 am

Comments are closed here.